.Merck defeats earnings requirements, raises sales expectation on powerful need for top medicines like Keytruda CNBCMerck & Co. (MRK US) Defeats Profit Estimates as Keytruda Sales Rise BloombergMerck Supply: Pharma Giant Posts Sturdy Outcomes, Yet Expectation Tumbles Short Entrepreneur's Service DailyMerck Announces Second-Quarter 2024 Financial Outcomes Yahoo FinanceMerck beats earnings as well as sales expectations surrounded by Keytruda strength, yet offers combined full-year overview MarketWatch.